Tempest Therapeutics (TPST) Treasury Shares (2011 - 2021)
Tempest Therapeutics (TPST) posted Treasury Shares of $114.7 million for Q4 2021, little changed sequentially from $114.7 million in Q4 2020, and little changed YoY from $114.7 million in Q4 2020.
Tempest Therapeutics (TPST) Treasury Shares (2011 - 2021) Analysis & Trends
Tempest Therapeutics has reported Treasury Shares for 10 years, with the latest figure at $114.7 million in Q4 2021.
- Quarterly Treasury Shares changed 0.0% year-over-year to $114.7 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $114.7 million (changed 0.0% YoY) and the FY2021 annual result came in at $114.7 million, changed 0.0% from the prior year.
- Treasury Shares was little changed at $114.7 million in Q4 2021 per TPST's latest filing, from $114.7 million in the prior quarter.
- Over five years, Treasury Shares peaked at $114.7 million in Q4 2020 and troughed at $50000.0 in Q1 2017.
- A 4-year average of $74.1 million and a median of $90.8 million in 2017 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2018 and 2021: Treasury Shares jumped 181597.03% in 2018, then changed 0.0% in 2021.
- Over 4 years, Treasury Shares stood at $90.8 million in 2017, then changed by 0.0% to $90.8 million in 2018, then gained by 26.24% to $114.7 million in 2020, then changed by 0.0% to $114.7 million in 2021.
- According to Business Quant data, Treasury Shares over the past three periods registered $114.7 million, $114.7 million, and $90.8 million for Q4 2021, Q4 2020, and Q3 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 2.72 Mn |
| 10 | Tempest Therapeutics | 4.23 Mn | 3.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 114.69 Mn |
| Dec 31, 2021 | 114.69 Mn |
| Dec 31, 2020 | 114.69 Mn |
| Dec 31, 2020 | 114.69 Mn |
| Sep 30, 2018 | 90.85 Mn |
| Sep 30, 2018 | 90.85 Mn |
| Jun 30, 2018 | 90.85 Mn |
| Jun 30, 2018 | 90.85 Mn |
| Mar 31, 2018 | 90.85 Mn |
| Mar 31, 2018 | 90.85 Mn |
| Dec 31, 2017 | 90.85 Mn |
| Dec 31, 2017 | 90.85 Mn |
| Jun 30, 2017 | 50,000.00 |
| Jun 30, 2017 | 50,000.00 |
| Mar 31, 2017 | 50,000.00 |
| Mar 31, 2017 | 50,000.00 |
| Dec 31, 2016 | 63.67 Mn |
| Dec 31, 2016 | 63.67 Mn |
| Sep 30, 2016 | 327,500.00 |
| Sep 30, 2016 | 327,500.00 |